Jan de Kraker
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 1%
- Neurology top 0.5%
- Pediatrics, Perinatology and Child Health top 0.5%
- Cancer Research top 2%
- Co-authors
- P.A. VoûteBengt SandstedtRosalyn SlaterHarm van TinterenHuib N. CaronNorbert GrafGordan VujanićCornelis A. Hoefnagel
- Topics
- Renal and related cancers (74 papers)Neuroblastoma Research and Treatments (38 papers)Renal cell carcinoma treatment (31 papers)
- Partner nations
- NetherlandsFranceUnited Kingdom
In The Last Decade
Jan de Kraker
145 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 3.4k
- Pulmonary and Respiratory Medicine 1.9k
- Neurology 1.5k
- Pediatrics, Perinatology and Child Health 1.4k
- Cancer Research 689
Countries citing papers authored by Jan de Kraker
This map shows the geographic impact of Jan de Kraker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan de Kraker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan de Kraker more than expected).
Fields of papers citing papers by Jan de Kraker
This network shows the impact of papers produced by Jan de Kraker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan de Kraker. The network helps show where Jan de Kraker may publish in the future.
Co-authorship network of co-authors of Jan de Kraker
This figure shows the co-authorship network connecting the top 25 collaborators of Jan de Kraker. A scholar is included among the top collaborators of Jan de Kraker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan de Kraker. Jan de Kraker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 61 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 81 | |
| 5 | 9 | |
| 6 | 20 | |
| 7 | 5 | |
| 8 | 12 | |
| 9 | A lack of neuroblastoma in Down syndrome: a study from 11 European countries. | 70 |
| 10 | 6 | |
| 11 | A constitutional balanced 1;17 neuroblastoma translocation | 1 |
| 12 | 11 | |
| 13 | [131I]MIBG as a first line treatment in advanced neuroblastoma. | 16 |
| 14 | 25 | |
| 15 | 38 | |
| 16 | 54 | |
| 17 | Side effects of I-131-MIBG therapy of neural crest tumors | 1 |
| 18 | 21 | |
| 19 | 15 | |
| 20 | 24 |
About Jan de Kraker
Jan de Kraker is a scholar working on Neurology, Urology and Pediatrics, Perinatology and Child Health, having authored 147 papers that have together received 5.6k indexed citations. Recurring topics across this work include Renal and related cancers (74 papers), Neuroblastoma Research and Treatments (38 papers) and Renal cell carcinoma treatment (31 papers). The work is most often cited by research in Neurology (1.5k citations), Pediatrics, Perinatology and Child Health (1.4k citations) and Pulmonary and Respiratory Medicine (1.9k citations). Jan de Kraker has collaborated with scholars based in Netherlands, France and United Kingdom. Frequent co-authors include P.A. Voûte, Bengt Sandstedt, Rosalyn Slater, Harm van Tinteren, Huib N. Caron, Norbert Graf, Gordan Vujanić, Cornelis A. Hoefnagel, Jan Godziński and Ivo Leuschner. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.